LEADER 02592nam  2200577 a 450 
001 9910957635903321
005 20251116181927.0
010   $a1-62417-791-3
035   $a(CKB)2550000001044199
035   $a(EBL)3022144
035   $a(SSID)ssj0001177368
035   $a(PQKBManifestationID)11793900
035   $a(PQKBTitleCode)TC0001177368
035   $a(PQKBWorkID)11154587
035   $a(PQKB)11108827
035   $a(MiAaPQ)EBC3022144
035   $a(Au-PeEL)EBL3022144
035   $a(CaPaEBR)ebr10687801
035   $a(OCoLC)839681853
035   $a(BIP)42957145
035   $a(BIP)42479123
035   $a(EXLCZ)992550000001044199
100   $a20121214d2013      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aDrug development $eprinciples, methodology and emerging challenges /$fMarco Rossi and Santina Bertone, editors
205   $a1st ed.
210   $aHauppauge, N.Y. $cNova Science Publishers, Inc.$d2013
215   $a1 online resource (118 p.)
225 1 $aPharmacology-research, safety testing and regulation
300   $aDescription based upon print version of record.
311 08$a1-62417-790-5 
320   $aIncludes bibliographical references and index.
327   $aOutsourcing and technology transfer / Dave Elder -- Analytical tools and chemometrics in drug development process : a review / D. Melucci, C. Locatelli and M. Locatelli -- Use of flow cytometry for drug development of cell cycle inhibitor : the example of edotecarin, a topoisomerase I inhibitor / Paolo Cappella ... [et al.] -- Antiproliferative effects of phenolic compounds isolated from Brazilian propolis / Soon-Chang Cho ... [et al.].
330   $aIn this book, the authors discuss the principles, methodology and emerging challenges of drug development. Topics include outsourcing and technology transfer in pharmaceutical companies; analytical tools and chemometrics in the drug development process; the use of cytometry for drug development of cell cycling inhibitors; and the antiproliferative effects of phenolic compounds isolated from the Brazilian propolis.
410  0$aPharmacology-research, safety testing, and regulation series.
606   $aDrug development
615  0$aDrug development.
676   $a615.1/9
701   $aRossi$b Marco$0307761
701   $aBertone$b Santina$01863520
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910957635903321
996   $aDrug development$94470169
997   $aUNINA